NEO News and Press, NeoGenomics Inc. From 05/09/23

2023-05-09 11:00:04 ET NeoGenomics ( NASDAQ: NEO ) added ~21% in the morning hours Tuesday as BTIG upgraded its shares to Buy from Neutral after the cancer-focused lab operator announced a strong topline beat and a guidance raise with its Q1 2023 results. With a $25 per ...

2023-05-08 20:57:03 ET NeoGenomics, Inc. (NEO) Q1 2023 Earnings Conference Call May 8, 2023, 04:30 PM ET Company Participants Kendra Sweeney - VP of IR Chris Smith - CEO Jeff Sherman - CFO Warren Stone - President of Clinical Service Division Vishal Sikri...

2023-05-08 16:26:12 ET NeoGenomics press release ( NASDAQ: NEO ): Q1 Non-GAAP EPS of -$0.09 beats by $0.06 . Revenue of $137.2M (+17.1% Y/Y) beats by $10.81M . Clinical Services revenue increased 16% to $115 million Pharma Services revenue increased 22% to ...

First Quarter Revenue Increased 17% to $137 Million FORT MYERS, FL / ACCESSWIRE / May 8, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the " Company " ), a leading provider of cancer-focused genetics testing services and global oncology contract research services, today announced its first-quarter...

FT. MYERS, FL / ACCESSWIRE / May 3, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced the company will be participating in the upcoming BofA Securities 2023 Healthcare Conference in...

FT. MYERS, FL / ACCESSWIRE / April 17, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that it will release its first quarter 2023 financial results on Monday, May 8, 2023. Along with the release, NeoGenomics wi...

FT. MYERS, FL / ACCESSWIRE / April 11, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that members of its management team will participate in a fireside chat at the 22 nd Annual...

FT. MYERS, FL / ACCESSWIRE / April 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology testing and global contract research services, announced today that the company and its collaborators will present a total of nine abstracts at the American Association for Cancer Research...

2023-04-04 16:12:08 ET NeoGenomics ( NASDAQ: NEO ) is maintaining its previously issued fiscal 2023 revenue and earnings guidance, adding that improving financial trends that began in 2022 are expected to continue this year. The company is projecting FY 2023 revenue of $54...

2023-03-31 15:00:41 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calenda...